Related by context. All words. (Click for frequent words.) 72 AAG geldanamycin analog 71 VEGFR2 inhibitor 71 LymphoStat B belimumab 70 diarrhea predominant irritable 70 oral nucleoside analogue 70 CYT# potent vascular disrupting 70 INSPIRE Trial Phase III 70 XL# anticancer compounds 70 refractory chronic lymphocytic 70 CYP#A# CYP#D# 70 lintuzumab SGN 70 Mg Uk 70 novel VDA molecule 69 humanized therapeutic 69 oral prodrug 69 kidney urologic 69 TRIOLEX HE# APOPTONE HE# 69 orally administered inhibitor 69 inflammatory PDE 69 Mg Usa 69 hyperphenylalaninemia HPA due 69 Pruvel ™ prulifloxacin 68 infliximab monotherapy 68 Panzem R 68 evaluating picoplatin 68 prokinetic agent 68 Pruvel TM 68 Amigal TM 68 Ribavirin causes 68 Budesonide foam crofelemer 68 Dementia Related Psychosis 68 refractory NSCLC 68 metastatic colorectal carcinoma 68 MKC# MT 68 Vitrasert R 68 recurrent metastatic ovarian cancer 68 2 methoxyestradiol 68 vaginal candidiasis 68 pan histone deacetylase 68 IMPDH inhibitor 67 R Saizen R 67 Crofelemer budesonide foam 67 C1 INH deficiency 67 essential thrombocythemia ET 67 systemic anaplastic large 67 IMiDs ® 67 myocardial infarction ventricular fibrillation 67 developing Bicifadine serotonin 67 Ovitrelle R Serostim 67 decompensated liver disease 67 plus prednisone prednisolone 67 Telik logo TELINTRA 67 includes TOLAMBA TM 67 nephropathic cystinosis cystinosis 67 doxepin HCl 67 CINQUIL 67 therapeutically inactive prodrug 67 Letairis ambrisentan 67 selective inverse agonist 67 including eniluracil ADH 67 toenail onychomycosis 67 naïve HCV 67 NS5B polymerase 67 induced mucositis 67 Epothilone D 67 6 sulfatase 67 AN# topical anti 67 candidates Azedra TM 67 5 HT2A serotonin 67 catheter occlusion 67 CDK cyclin dependent 67 YOUR LOCAL ANIMAL SHELTER 67 hypertrichosis occurred 67 D aspartate NMDA receptor 67 delta opioid receptor 67 dasatinib Sprycel ® 66 5 FU leucovorin 66 class mGluR5 inhibitor 66 albiglutide 66 dimebon latrepirdine 66 5 HT2A inverse 66 FOLFOX6 chemotherapy regimen 66 MAGE A3 ASCI 66 selective modulator 66 reduce serum phosphate 66 MTP inhibitor 66 non nucleoside inhibitor 66 development peramivir neuraminidase 66 receiving XGEVA 66 formerly LymphoStat B 66 aplindore 66 mGluR5 negative 66 sorafenib tablets 66 metaglidasen 66 approved incretin mimetic 66 infectious diseases autoimmune diseases 66 R sorafenib tablets 66 virus HCV protease inhibitor 66 vascular occlusive diseases 66 pralatrexate injection folate analogue 66 recombinant PSMA vaccine 66 TNF Tumor Necrosis Factor 66 small molecule Hedgehog 66 Meets Primary Endpoint 66 GVAX ® 66 DG# compounds targeting 66 ATRA IV 66 neuromuscular spasm 66 mitoxantrone plus 66 opioid naive 66 Darinaparsin 66 IAP inhibitor 66 Oral NKTR 66 Refractory Hodgkin Lymphoma 66 weekly subcutaneous injections 66 NEBIDO VANTAS SUPPRELIN LA 66 HGS ETR1 mapatumumab 66 evaluating mipomersen 66 markets COLAZAL 66 metformin sulfonylurea 66 TRIOLEX ™ 66 brand ciclesonide HFA 66 candidate XP# 66 headache nasopharyngitis 66 nilotinib Tasigna ® 66 Rigel R# 66 MCSP respectively 66 albiglutide currently 66 IMiDs R 66 CIMZIA r certolizumab pegol 66 novel synthetic PEGylated 65 Empatic ™ 65 targeted radiotherapeutic 65 alkylating agent 65 Tasigna prolongs 65 interferon alpha IFN 65 IBS C 65 dependent kinase inhibitor 65 clinical trials Archexin 65 Aflibercept 65 anthracycline taxane 65 mGluR2 positive 65 estrogen receptor beta agonist 65 relapsed MM 65 PLX STROKE targeting 65 topical gel formulation 65 PEGylated Fab fragment 65 allosteric modulator PAM 65 NU# direct 65 myelodysplastic myeloproliferative diseases 65 ENL recurrence 65 novel emulsion formulation 65 mGluR5 NAM 65 cladribine Cladribine Tablets 65 combines bupropion 65 R rilonacept Injection 65 CYP#A# isoenzyme 65 MKC# 65 CTAP# Capsules 65 pharmacogenomic translational research 65 Shigatoxin producing E. coli 65 influenza BCX# purine nucleoside 65 Suppository Hydrocortisone Acetate Rectal 65 IgG1 monoclonal antibody 65 induced macular edema 65 delivers fluocinolone acetonide FA 65 Naive Patients 65 iloprost synthetic compound 65 By JENNIFER LEARN 65 prednisone prednisolone plus 65 Atripla combines 65 diarrhea dyspepsia 65 hypereosinophilic syndrome 65 RAS MAPK pathway 65 novel antimitotic agent 65 AKT inhibitor 65 ALN HPN 65 solid tumors ZYBRESTAT 65 Emtriva Viread 65 oral picoplatin 65 CYT# QbG# 65 PRN FDA Approves 65 Personalized Immunotherapy 65 undergoing elective percutaneous 65 Complicated Skin 65 oral rivaroxaban 65 delta gamma agonist 65 acute peptic ulcer 65 Gabapentin GR TM 65 peripherally acting 65 interferon gamma 1b 65 headache abdominal pain 65 polycythemia vera essential thrombocythemia 65 haematologic 65 neutropenia dehydration dyspnea 65 PNP inhibitor 65 RhuDex R 65 interferon beta 1a infertility 65 alvespimycin 65 R lenalidomide 65 de novo kidney transplant 65 Pegloticase 65 RhuDex TM 65 generation purine nucleoside 65 CHEAP ONLINE PHARMACY LOW 65 particularly SANCTURA XR 65 dopamine D2 65 hypoxia activated prodrug 65 ergot derivatives 65 Pharma Merck Serono 65 BENLYSTA TM 65 investigational pharmacologically unique 65 Demonstrates Positive 65 palonosetron hydrochloride Injection Dacogen 65 Solzira TM 65 HCV NS5B polymerase 64 beta 1a 64 dyslipidemia abnormal 64 hoFH 64 oral dihydropyrimidine dehydrogenase DPD 64 bone marrow reticulin deposition 64 muscarinic receptor agonist 64 torsemide ER 64 CK # administered 64 relapsed Acute Myeloid 64 Prodarsan R 64 pathophysiological effects 64 Randomized Double blind 64 candidate SILENOR TM 64 Pivotal Phase 64 methylnaltrexone bromide 64 pneumocystis pneumonia PCP 64 MEK Inhibitor 64 develop HBV reactivation 64 Retisert R 64 FUSILEV enhances 64 adjuvant GIST 64 metastatic malignant 64 Submits Biologics License Application 64 vitreous floaters 64 SILENOR TM doxepin HCl 64 certain protein tyrosine 64 retinal vein occlusion induced 64 forodesine 64 galiximab 64 Vidaza ® 64 cancer indications bafetinib 64 inverse agonist 64 papillary renal cell carcinoma 64 stage IIIb IV 64 XP# XP# 64 chronic eosinophilic leukemia 64 Initiates Phase II 64 R roscovitine CDK cyclin 64 Amgen Neulasta R 64 Achieves Primary Endpoint 64 taxane chemotherapy administered 64 either acutely decompensated 64 ® bortezomib 64 steroid refractory ulcerative 64 refractory gout 64 oral proteasome inhibitor 64 neuropathic pain spasticity 64 alfimeprase direct 64 sulfonylhydrazine class 64 Gel repository corticotropin injection 64 relapsed leukemia 64 opioid induced bowel dysfunction 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 TBC# 64 humanized interleukin 6 64 neutropenia thrombocytopenia 64 Vascular Disrupting Agent 64 Intravitreal injections 64 sapropterin dihydrochloride Phase 64 Sodium oxybate 64 Plicera TM 64 RANK Ligand inhibitor 64 R#/MEM # 64 Acute Exacerbations 64 norepinephrine reuptake inhibitor 64 PEGINTRON TM 64 ragweed allergy immunotherapeutic 64 refractory cutaneous T 64 abacavir lamivudine 64 ® lenalidomide 64 Pharmacokinetics PK 64 Peginterferon alfa 2b 64 thrombin component 64 semi synthetic lipoglycopeptide 64 Frozen Shoulder syndrome Adhesive 64 Teriflunomide 64 aMCI precursor 64 CG# oncolytic virus 64 hA# 64 indinavir Crixivan 64 Hormone Refractory Prostate Cancer 64 dyskinesia PD LID 64 forodesine purine nucleoside phosphorylase 64 Trial Evaluating 64 K ras mutations 64 receptor inhibitor 64 CTA# Injection 64 rash pruritus nausea 64 NS5b 64 serologically active systemic lupus 64 GERD migraine headaches 64 Luramist TM 64 TO AVOID PREGNANCY WHILE 64 PI3K/Akt pathway inhibitor 64 SPRYCEL ® 64 gastrointestinal stromal 64 REGN# 64 demonstrated antitumor activity 64 alpha folate receptor 64 oral isoform selective HDAC 64 clinical trials Archexin ® 64 Announces Tentative Approval 64 adenosine injection 64 hormone LHRH antagonist 64 trastuzumab Herceptin R 64 PRICE GREAT DISCOUNT FREE 64 novel orally inhaled 64 IMiDs ® compound 64 dextromethorphan quinidine 64 Acetate Rectal Suppositories 64 erlotinib Tarceva ® 64 ACAPODENE TM 64 overactive bladder AA# 64 novel histone deacetylase 64 Completes Patient Enrollment 64 intravenous RSD# 64 pharmacodynamic profiles 64 novel topoisomerase 64 Oral Calcitonin 64 Lenocta TM sodium stibogluconate 64 CYP#A# substrate 64 2A receptor agonist 64 MKC# MKC# PP 64 topically applied SEPA 64 carcinoma mCRC 64 Panzem R NCD 64 5 HT2C 63 investigational oral inhibitor 63 injectable investigational 63 EOquin TM phase 63 5 lipoxygenase inhibitor 63 fusion enhancers 63 Sudhir Agrawal D.Phil 63 phenylalanine ammonia lyase 63 evaluating tivozanib 63 cardiac myosin activator omecamtiv 63 intravesical infusion therapy 63 Methylnaltrexone 63 ocular formulation 63 non porcine pancreatic 63 COPEGUS R 63 investigational humanized monoclonal antibody 63 Luveris R Ovidrel R 63 somatostatin analog 63 Warner Chilcott Actonel 63 sarcoma melanoma 63 cortisol synthesis 63 Xeloda ® 63 malignancy HCM 63 itraconazole Sporanox 63 tumor xenograft models 63 included exfoliative dermatitis 63 4mg/kg 63 Relapsed Refractory 63 homozygous familial hypercholesterolemia 63 infection epistaxis dyspnea exfoliative 63 Hsp# Inhibitor 63 Parkinson disease levodopa induced 63 Archexin 63 castration resistant hormone refractory 63 oral ghrelin agonist 63 anaphylactic reactions bronchospasm 63 allosteric modulator NAM 63 Adenoscan R 63 specifically hypoactive sexual 63 cisplatin gemcitabine 63 BCG refractory carcinoma 63 compound INCB# 63 used DNA alkylating 63 ASH Abstract # 63 include Phenoptin TM 63 moderate renal impairment 63 TRX1 63 familial hypercholesterolemia FH 63 Serostim ® 63 Xcytrin R 63 induce orthostatic hypotension 63 Retisert ® 63 Phase 2b Clinical Trial 63 selective phosphodiesterase 63 Second Pivotal Phase 63 constipation predominant irritable bowel 63 arsenic trioxide injection 63 Pruvel 63 resistant hormone refractory 63 ara C 63 selective A2A adenosine receptor 63 LX# LX# 63 receptor tyrosine kinase inhibitor 63 acute mania 63 Exelixis compounds 63 modified glutathione analog 63 familial amyloidotic polyneuropathy FAP 63 atypical hemolytic uremic syndrome 63 involuntary dyskinetic movements 63 neuronal nicotinic receptor NNR 63 J Am Coll 63 recurrent genital herpes 63 gets USFDA nod 63 isolated hypertriglyceridemia 63 migraine headaches neuropathic pain 63 Begins Dosing 63 huN# DM1 63 Daclizumab 63 vapreotide acetate 63 Initiate Phase 63 azilsartan medoxomil 63 evaluating satraplatin 63 damage cirrhosis liver 63 EGFr expressing mCRC 63 IMiDs 63 PEGylated docetaxel 63 retinal thrombosis hemorrhages 63 erosive gastritis 63 g trans fats 63 hyperplasia BPH 63 vitreoretinal disorders 63 Pivotal Phase III 63 Phase Ib clinical trials 63 novel chimeric natriuretic 63 Annamycin 63 antidepressants fluoxetine 63 cytarabine daunorubicin 63 mertansine 63 severe hypercholesterolemia 63 treatment naïve genotype 63 oral vancomycin 63 psoriasis Crohn disease 63 GRNOPC1 contains 63 rheumatoid arthritis psoriatic arthritis 63 Contrave# 63 DIFICID ™ 63 relapsing remitting MS RRMS 63 SinuNase TM 63 Leukopenia neutropenia 63 complement inhibitor eculizumab 63 Diffuse Large B 63 inflammatory autoimmune diseases 63 CML CP 63 investigational monoclonal antibody 63 d l leucovorin 63 DEB# 63 multicenter Phase III 63 ADVANCE ILLUMINATE 63 Hydrochlorothiazide Tablets 63 Testosterone MDTS R 63 atherosclerosis rheumatoid arthritis 63 patients coinfected 63 sapacitabine CYC# 63 phenylketonuria PKU developed 63 gemcitabine Gemzar ® 63 mTOR mammalian target 63 NASH Huntington 63 ® adefovir dipivoxil 63 pharmacologically active isomer 63 Cardium Therapeutics TM 63 acetonide FA 63 phase III isavuconazole 63 Vitrasert ® 63 inhibitor COX 63 CTAP# 63 Silodosin 63 CIMZIA TM certolizumab pegol 63 advanced medullary thyroid 63 multiple sclerosis psoriasis 63 treat chronic sinusitis 63 exocrine pancreatic insufficiency EPI 63 Entereg R 63 testing huN# DM1 63 sitaxsentan 63 Initiates Clinical Trial 63 Hedgehog Pathway Inhibitor 63 receiving chemoradiation therapy 63 PEG PAL 63 unresectable tumors 63 pancreatic prostate 63 acyclovir Lauriad R 63 visilizumab 63 ADP receptor antagonist 63 cyclophosphamide doxorubicin vincristine 63 oral Janus kinase 63 #.#mg/dL 63 CYT# vascular disrupting 63 protein tyrosine phosphatase 1B 63 PORxin TM platforms 63 primary hypercholesterolemia 63 ZOLINZA 63 Presents Positive 63 NMDA N 63 Solazed TM 63 myelofibrosis polycythemia vera 63 Oral Fingolimod 63 polyneuropathy HIV DSP 63 Albuferon TM 63 liposomal formulation 63 mg q#h 63 memantine HCl 63 TRANSDUR ® 63 Elestrin ® 63 Primary Hypercholesterolemia 63 hypothyroidism hyperglycemia hypotension arrhythmihemorrhagic colitis development 63 COLAZAL R 63 aminotransferase levels 62 8mg/kg 62 serum phosphorous 62 Macular edema 62 ® chorionic gonadotropin 62 relapsed refractory multiple myeloma 62 non splenectomized 62 unresectable locally advanced 62 INVEGA ® 62 orally inhaled migraine 62 Randomized Phase II 62 cutaneous T 62 psoriasis rheumatoid arthritis 62 HCV RNA polymerase 62 ARIKACE ™ 62 cMET 62 FEMALES SHOULD BE ADVISED 62 PDX pralatrexate 62 Bezielle 62 Novel Oral 62 NSAID associated 62 Tyrosine Kinase Inhibitor 62 ceftazidime 62 antiangiogenesis therapies 62 metastatic HRPC 62 vitamin B# folic acid 62 primidone 62 Orally administered 62 receiving VELCADE 62 Phase 2b Trial 62 gemifloxacin mesylate tablets fluoroquinolone 62 Elotuzumab 62 LHRH antagonists 62 interferon alpha IFN alpha 62 PEGylated anti 62 huC# DM4 62 mecarbil 62 lenalidomide Revlimid R 62 chemosensitizer 62 Fovea Pharmaceuticals subsidiary 62 Patients Treated With 62 worsening thrombocytopenia 62 triggers apoptosis programmed 62 M# rationally 62 inhalations twice 62 R ferumoxytol Injection 62 refractory chronic myeloid 62 CCR5 mAb 62 including cyclosporine methotrexate 62 advanced metastatic renal 62 Zorbtive TM 62 solanezumab 62 THIS COMMISSION 62 erlotinib Tarceva R 62 substantially excreted 62 ABLYNX 62 piperacillin tazobactam 62 angiotensin analog 62 Janus kinase 62 corticosteroid dexamethasone 62 HBeAg negative 62 zileuton injection 62 cromolyn sodium 62 ALN VSP Phase 62 Zenvia ™ 62 Aztreonam lysine 62 systemic juvenile idiopathic 62 davunetide intranasal AL 62 5 HT1A receptor 62 lymphomas leukemias 62 ENMD # 62 OMNARIS HFA 62 generation antisense inhibitor 62 administered concomitantly 62 evaluating T DM1 62 hypoxia selective 62 cyclophosphamide methotrexate 62 elderly myelodysplastic syndromes 62 ovarian esophageal 62 Tarceva TM 62 Shows Statistically Significant 62 Granted Orphan Drug 62 octreotide implant 62 NATIONAL ECONOMIC COUNCIL DIRECTOR 62 lead Aganocide compound 62 evaluating satraplatin plus 62 Randomized Phase 62 ritonavir boosted 62 personalized cellular immunotherapy 62 iobenguane 62 Curis collaborator Genentech 62 linoleic acid LA 62 COLAZAL ® 62 CIMZIA ™ 62 gastrointestinal mucositis 62 arthritis PsA 62 oropharyngeal candidiasis OPC 62 non nucleoside HCV 62 Dosa suffers 62 TELINTRA R 62 Epivir R 62 syndrome gastroesophageal reflux 62 Ph + acute lymphoblastic 62 sodium glucose cotransporter 62 irinotecan cisplatin 62 Neovascular Age Related Macular 62 malignant mesothelioma Alfacell 62 sulfonylurea glimepiride 62 TNF alpha selectively neutralizing 62 NR2B selective 62 HIV treatments Reyataz 62 asymptomatic metastatic 62 SPL# Gel vaginal microbicide 62 Known hypersensitivity 62 VELCADE melphalan 62 Tolvaptan 62 accumulate preferentially 62 candesartan cilexetil 62 Initiates Phase III 62 TKB# 62 Obatoclax 62 Aeolus Pharmaceuticals Announces 62 QNEXA ® 62 Provectus Pharmaceuticals specializes 62 Xanafide 62 Kit CD# positive 62 Transgenomic Pharmacogenomics Services 62 Combination REOLYSIN R 62 drugs cough suppressant 62 dexamethasone Decadron 62 MSCRAMM ® 62 DITPA 62 Phase 2a Clinical Trial 62 Initiates Enrollment 62 herpetic keratitis 62 miconazole Lauriad ® 62 Interferon beta 1a 62 Forodesine HCl 62 hypertension osteoarthritis 62 treats paroxysmal nocturnal 62 Lubiprostone 62 polysaccharide polymer 62 manufactures minimally invasive 62 receiving INTRON 62 Diabetic macular edema 62 docetaxel Taxotere R 62 Azacitidine 62 radiation enteritis 62 Vytorin combines 62 treat benign prostatic 62 AzaSite Plus 62 smoldering multiple myeloma 62 J Antimicrob Chemother 62 gastrointestinal disorders ATI 62 ACTEMRA TM 62 q8h 62 3 registrational trial 62 Atypical Hemolytic Uremic Syndrome 62 Alimentary Tract 62 signal transduction inhibitor 62 Presents Preclinical 62 #mg/day [002] 62 octreotide acetate 62 Receives Orphan Drug Designation 62 Factor Receptor 62 systemic Phase 1b 62 progressive metastatic prostate 62 Genentech sanofi aventis 62 advanced carcinoid 62 5 fluorouracil leucovorin 62 highly selective endothelin 62 Cannabinor 62 Fludarabine 62 diarrhea headache nausea 62 Randomized Double Blind 62 corticotropin injection 62 concomitant cardiac 62 5 FU capecitabine 62 Sphingomab TM 62 ALN PCS 62 evaluating Xcytrin 62 metastatic ocular 62 oxypurinol 62 severely active polyarticular 62 hypophosphatemia 62 Multiple Ascending Dose 62 include Healive TM 62 Quepasa Corporation headquartered 62 ASONEP ™ 62 Phase IIb Trial 62 Investigational Oral 62 diarrhea vomiting nausea 62 severe malignant osteopetrosis 62 R memantine HCl 62 Investigational Treatment 62 highly purified pasteurized 62 Testosterone MDTS ® 62 interferon alfa 2b 62 previously untreated follicular 62 evaluating intravenous picoplatin 62 Syncria R 62 Myelofibrosis 62 HCD# [002] 62 candidates Augment ™ 62 pancreatic insufficiency 62 cirrhotic CHC monoinfected patients 62 irinotecan containing 62 Auxilium transmucosal film 61 fumarate 61 SinuNase ™ 61 RezularTM 61 combining voreloxin 61 structure infections ABSSSI 61 systemically administered 61 syndrome IBS 61 diabetic peripheral neuropathic DPN 61 diabetic neuropathic pain 61 mg TID 61 vi Immtech ability 61 metformin sulfonylureas 61 constipation OIC 61 GATTEX ™ 61 Postherpetic neuralgia PHN 61 product platforms AZX# 61 aldehyde dehydrogenase ALDH2 deficiency 61 Pooled Analysis 61 clinical trials dacetuzumab SGN 61 Optiquel ™ 61 TO TREAT 61 Vicriviroc 61 folate analogue metabolic 61 delivery polymer matrix 61 zoledronic acid Reclast 61 HMG CoA reductase inhibitors 61 Cytogen marketed 61 5 HT4 61 biliary tract cancer 61 #/#/# Cytokinetics Incorporated 61 Commences Phase 61 esophageal candidiasis 61 R# #mg BID 61 IIIa inhibitor 61 specific CCR9 antagonist 61 omecamtiv mecarbil 61 humanised monoclonal antibody 61 elotuzumab 61 multi kinase inhibitor 61 neutropenia fatigue 61 DNA methyltransferase inhibitors 61 ADL# novel 61 developing Surfactant Replacement 61 ENABLE Phase 2 61 lexidronam injection 61 rheumatoid arthritis inflammatory bowel 61 LHRH receptor positive 61 severe hypersensitivity reactions 61 achieved ACR# 61 related CMV Retinitis 61 nausea dehydration dyspnea 61 fungal infections malaria tuberculosis 61 lead molecular radiotherapeutic 61 fibrosis IPF 61 hepatic lipase 61 novel L DOS# 61 Tezampanel 61 mocetinostat MGCD# 61 indolent follicular non 61 pan HDAC inhibitor 61 taxane refractory 61 Aganocide 61 TNF blocker therapy 61 valtorcitabine 61 metastatic GIST 61 VP# [004] 61 LymphoStat B TM 61 reversible inhibitor 61 EGFr expressing metastatic colorectal 61 leukemia AML 61 delivers preprogrammed intermittent 61 vaccinated PNH patients 61 systemic lupus erythematosus rheumatoid 61 Completes Enrollment 61 bucindolol hydrochloride 61 bone spurs bulging 61 mucus plugging 61 generation PNP inhibitor 61 Cojocaru correspondent 61 sapropterin dihydrochloride Tablets 61 OMP #R# 61 intranasal formulation 61 METOZOLV ™ ODT metoclopramide 61 potent CYP#A# inhibitors 61 Firdapse TM amifampridine phosphate 61 hematological parameters 61 glucagon receptor 61 integrin inhibitor 61 ropinirole Requip 61 Induces Apoptosis 61 sunitinib Sutent ® 61 undergoing hematopoietic stem 61 basal bolus therapy 61 Bayer HealthCare Onyx Pharmaceuticals 61 Novartis Trileptal 61 hypertension pulmonary arterial 61 individualized cellular immunotherapy 61 5 HT2A receptor 61 Acetavance TM intravenous acetaminophen 61 urate lowering 61 pseudobulbar affect PBA 61 rusalatide acetate 61 anti VEGF aptamer 61 selective agonist 61 Non Alcoholic Steatohepatitis 61 Initiate Clinical Trial 61 leukemia multiple myeloma 61 Files IND 61 doxorubicin cyclophosphamide 61 ASG 5ME dacetuzumab SGN 61 hematological cancers notably 61 Ocrelizumab 61 Zenvia TM 61 steroid refractory 61 SGPT 61 dyslipidemia hypertension diabetes 61 modulate ion channel 61 budesonide foam 61 inhalant addiction 61 insomnia somnolence 61 Kinesin Spindle Protein KSP 61 urinary N telopeptide 61 AGILECT R 61 ALISTA TM 61 #HT# 61 Coadministration 61 interleukin IL -# 61 Ostabolin C TM 61 THR beta agonist 61 recurrent glioblastoma multiforme 61 Acute Intermittent Porphyria 61 oral antidiabetic medication 61 Staccato prochlorperazine 61 boxer dachshund bulldog 61 CTAP# Injection 61 pruritus rash 61 treat hyperphosphatemia 61 developing KL4 surfactant 61 psoriasis inflammatory bowel 61 vomiting anorexia stomatitis 61 accompanying electrolyte abnormalities 61 HQK 61 hereditary emphysema 61 Pathway Inhibitor 61 jeanswear outerwear packs 61 taxane resistant 61 thalidomide Thalomid 61 refractory indolent non 61 vidofludimus 61 occlusion PAO 61 cetuximab Erbitux R 61 irreversible inhibitor 61 vinca alkaloid 61 Bilive R combined 61 Veronate R 61 dasatinib Sprycel 61 metastatic carcinoid 61 adriamycin 61 PresbyLens ® 61 generation Hsp# inhibitor 61 Soft Tissue Sarcoma 61 Dose Ranging Study 61 OvaRex R 61 RNAi therapeutic targeting PCSK9 61 e antigen HBeAg 61 Hos2 61 systemic corticosteroid 61 nanofiltered plasma derived 61 deep venous thromboses 61 Ophena TM 61 Alfacell proprietary ribonuclease 61 Adjuvant Treatment 61 Initiated Phase 61 Tibotec Therapeutics division 61 convulsive disorders 61 PEGylated interferon beta 1a 61 diabetes sciatica 61 aurora kinase 61 headache tiredness dizziness 61 Demonstrates Sustained 61 JAK2 Inhibitor 61 dizziness imbalance 61 polyglutamate 61 Vertex hepatitis C 61 abnormal p# 61 Neulasta R 61 Ondansetron Injection USP 61 Cloretazine ® 61 idiopathic thrombocytopenic purpura ITP 61 AQD class 61 potent antiproliferative 61 Augment TM 61 INCB# [001] 61 Initiate Phase III 61 mesylate tablets fluoroquinolone antibiotic 61 fatigue abdominal pain 61 rilonacept Injection 61 First Patient Dosed 61 Recurrent Glioblastoma 61 prednisone CHOP 61 mild vasodilator 61 inhibit oxidative stress 61 PMX # heptagonist 61 acute peripheral arterial 61 Central Retinal Vein 61 tolvaptan 61 alfa 2a 61 rabeprazole 61 sublingual tablet formulation 61 novel tubulin binding 61 HCV polymerase inhibitors 61 pancreatic alpha 61 sodium thiosulfate STS 61 Dapagliflozin 61 Angiotensin Converting Enzyme 61 diabetic gastroparesis 61 pomalidomide 61 pipeline ImmunoGen collaborators 61 nonalcoholic steatohepatitis 61 drugs FUSILEV 61 inhibitor PPI 61 glutamic acid decarboxylase 61 Romidepsin 61 Zollinger Ellison Syndrome 61 Dupuytren Disease 61 autoantibody levels 61 reslizumab 61 antiretroviral naive 61 stent neointimal growth 61 orally inhaled 61 Leukemia AML 61 receiving immunosuppressive therapy 61 PD LID 61 Capsulitis 61 chemotherapy molecularly targeted 61 posaconazole 61 depressive episodes associated 61 Telithromycin 61 Phase #b/#a clinical 61 xanthine oxidase inhibitor 61 Glufosfamide 61 Selzentry Celsentri 61 secretory phospholipase A2 61 highly selective inhibitor 61 S1P antibody 61 Genentech Rituxan 60 unresectable Stage III 60 RDEA# potent 60 fluoxetine HCl 60 Phase IIa Clinical Trial 60 severe hepatic dysfunction 60 4 PDE4 enzyme 60 chronic progressive neurodegenerative 60 class anticancer quinolone 60 please visit http:/www.vandapharma.com 60 non thiazolidinedione TZD 60 pyrexia mucositis sepsis febrile 60 subcutaneously administered 60 systemic lupus erythematosus psoriasis 60 Bronchopulmonary Dysplasia 60 infectious diseases autoimmune 60 deCODE AF TM 60 Wafer polifeprosan 60 lamotrigine Lamictal 60 MET VEGFR2 60 imatinib resistant 60 Cholinesterase Inhibitors 60 diabetes irritable bowel 60 novel therapeutic antibodies 60 Indibulin ZIO 60 AzaSite ISV 60 Relapsing Remitting Multiple Sclerosis 60 Sei un appassionato o